Clinical Research Directory
Browse clinical research sites, groups, and studies.
Aripiprazole in Body Focused Repetitive Behaviors
Sponsor: University of Chicago
Summary
This study is 6 weeks long and involves subjects taking aripiprazole or placebo. If they are randomly assigned to the aripiprazole arm and are eligible to participate in the study, they will begin by taking 5mg once daily of aripiprazole for two weeks, then 10mg once daily for the remaining three weeks. Efficacy and safety measures will be performed at each visit. Participants will be randomized to receive either aripiprazole or placebo on a 1:1 basis. This blinding will be maintained by the IDS pharmacy at the University of Chicago.
Official title: A Double-Blind, Placebo Controlled Study of Aripiprazole in Body Focused Repetitive Behaviors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-06
Completion Date
2027-12
Last Updated
2025-10-02
Healthy Volunteers
No
Interventions
Placebo
A drug that contains no medicine
Aripiprazole
Atypical antipsychotic medication
Locations (1)
University of Chicago
Chicago, Illinois, United States